BIOCRYST PHARMACEUTICALS INC
Acción · US09058V1035 · BCRX · 896047 (XNAS)
10,25 USD
13.06.2025 23:27
Cotizaciones actuales de BIOCRYST PHARMACEUTICALS INC
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NASDAQ |
BCRX
|
USD
|
13.06.2025 23:27
|
10,25 USD
| 10,40 USD
-1,44 %
|
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,00 % | -6,82 % | 4,06 % | 33,12 % | 36,12 % | 66,13 % | 138,93 % |
Perfil de la empresa para BIOCRYST PHARMACEUTICALS INC Acción
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Fondos invertidos
Los siguientes fondos han invertido en: BIOCRYST PHARMACEUTICALS INC invertido:
Fondo | Vol. en millones 92,09 | Porcentaje (%) 0,22 % |
Datos de la empresa
Nombre BIOCRYST PHARMACEUTICALS INC
Empresa BioCryst Pharmaceuticals, Inc.
Símbolo BCRX
Sitio web
https://www.biocryst.com
Mercado principal
NASDAQ

WKN 896047
ISIN US09058V1035
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Mr. Jon P. Stonehouse
Capitalización de mercado 2 Mrd.
País Estados Unidos de América
Moneda USD
Empleados 0,6 T
Dirección 4505 Emperor Boulevard, 27703 Durham
Fecha de OPV 1994-03-04
Símbolos de cotización
Nombre | Símbolo |
---|---|
Frankfurt | BO1.F |
NASDAQ | BCRX |
Otras acciones
Los inversores que tienen BIOCRYST PHARMACEUTICALS INC también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.